Telmisartan
Hypertension and heart failure | Cardiovascular System
Items (National)
339.1K
NHS Cost
£2.5M
Practices
5,849
Avg per Practice
58
Overview
Telmisartan is prescribed by 5,849 GP practices across England. In the last 12 months, 339,094 items were prescribed at a total cost of £2,501,416 to the NHS. It is classified under BNF Chapter Cardiovascular System, Section Hypertension and heart failure.
Monthly Prescribing Trend
Jun 2026
21,969
Jun 2026
20,639
Jun 2026
22,296
Jun 2026
22,389
Jun 2026
21,589
Jun 2026
22,645
Jun 2026
21,845
Jun 2026
22,054
Jun 2026
22,327
Jun 2026
20,010
Jun 2026
21,122
Jun 2026
20,977
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| PE | 13.5K | 80 | 169 | +191.7% ▲ |
| BS | 12.4K | 76 | 163 | +181.6% ▲ |
| LE | 10.3K | 109 | 95 | +63.1% ▲ |
| TN | 9,571 | 65 | 147 | +153.8% ▲ |
| GU | 9,551 | 66 | 145 | +149.5% ▲ |
| OL | 9,413 | 56 | 168 | +189.8% ▲ |
| M | 8,569 | 150 | 57 | -1.6% vs avg |
| B | 8,208 | 178 | 46 | -20.5% ▼ |
| BN | 7,992 | 71 | 113 | +94.1% ▲ |
| E | 7,182 | 112 | 64 | +10.5% ▲ |
| L | 7,176 | 124 | 58 | -0.2% vs avg |
| S | 6,975 | 115 | 61 | +4.7% ▲ |
| DN | 6,538 | 74 | 88 | +52.4% ▲ |
| NR | 5,937 | 67 | 89 | +52.8% ▲ |
| KT | 5,720 | 55 | 104 | +79.3% ▲ |
| RH | 5,643 | 50 | 113 | +94.7% ▲ |
| TW | 5,270 | 63 | 84 | +44.3% ▲ |
| IP | 5,232 | 55 | 95 | +64.0% ▲ |
| NE | 5,145 | 83 | 62 | +6.9% ▲ |
| NN | 5,039 | 60 | 84 | +44.8% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| THE ROYTON & CROMPTON FAMILY PRACTICE | 5,302 |
| MUNRO MEDICAL CENTRE | 3,534 |
| THE HILL SURGERY | 1,446 |
BNF Classification
- Chapter: Cardiovascular System
- Section: Hypertension and heart failure
- Paragraph: Renin-angiotensin system drugs
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.